sansik 5 mg filmtabletta
zentiva, k.s. (csehország) - linagliptin -
egiramlon 2,5 mg/2,5 mg kemény kapszula
egis gyógyszergyár zrt. - a ramipril; amlodipin -
egiramlon 5 mg/10 mg kemény kapszula
egis gyógyszergyár zrt. - a ramipril; amlodipin -
egiramlon 5 mg/5 mg kemény kapszula
egis gyógyszergyár zrt. - a ramipril; amlodipin -
egiramlon 10 mg/10 mg kemény kapszula
egis gyógyszergyár zrt. - a ramipril; amlodipin -
egiramlon 10 mg/5 mg kemény kapszula
egis gyógyszergyár zrt. - a ramipril; amlodipin -
ikervis
santen oy - ciklosporin - szaruhártya betegségek - szemészeti - súlyos keratitis kezelése száraz szem betegségben szenvedő felnőtt betegeknél, amely nem javult a könnycseppek kezelésével szemben.
droperidol injekció
richter gedeon nyrt. - droperidol -
azacitidine celgene
celgene europe bv - azacitidinnel - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - daganatellenes szerek - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.
azacitidine mylan
mylan ireland limited - azacitidinnel - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - daganatellenes szerek - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.